CRISPR technology: A versatile tool to model, screen, and reverse drug resistance in cancer

Shiva Shirani-Bidabadi; Aliye Tabatabaee; Nazita Tavazohi; Amirali Hariri; Amir Reza Aref; Ali Zarrabi; Nicolette Casarcia; Anupam Bishayee; Mina Mirian

doi:https://doi.org/10.1016/j.ejcb.2023.151299

CRISPR technology: A versatile tool to model, screen, and reverse drug resistance in cancer

Identifier:nobleid.org/w1/20260418/6C2C7B97

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/6C2C7B97.svg?ark=w1%2F20260418%2F6C2C7B97)](https://nobleid.org/work/w1/20260418/6C2C7B97)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Shiva Shirani-Bidabadi

Claim authorship of this work

CRISPR technology: A versatile tool to model, screen, and reverse drug resistance in cancer

Identifier:nobleid.org/w1/20260418/6C2C7B97

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/6C2C7B97.svg?ark=w1%2F20260418%2F6C2C7B97)](https://nobleid.org/work/w1/20260418/6C2C7B97)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Shiva Shirani-Bidabadi

Claim authorship of this work